// App-Quantinova.ai

: Use of JAK 2 v617f As a Hypercoagulable Test in a Community Hospital

Researchers

Presenter

  • Danny Landau

Principal Investigators

  • N/A

Medical Centers

  • Orlando Health Cancer Center, Orlando, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Janus kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved